Challenges and differences in external radiation therapy for retinoblastoma: from standard techniques to new developments

Tumori
Ayşe HiçsönmezMeltem Nalça Andrieu

Abstract

The purpose of this study is to calculate the treatment plans and to compare the dose distributions and dose-volume histograms (DVH) for 6 external radiotherapy techniques for the treatment of retinoblastoma as well as intensity-modulated radiotherapy (IMRT) and fractionated stereotactic radiotherapy (Cyberknife). Treatment plans were developed using 6 techniques, including an en face electron technique (ET), an anterior and lateral wedge photon technique (LFT), a 3D conformal (6 fields) technique (CRT), an inverse plan IMRT, tomotherapy, and conventional focal stereotactic external beam radiotherapy with Cyberknife (SBRT). Dose volume analyses were carried out for each technique. All techniques except electron provided similar target coverage. When comparing conformal plan with IMRT and SBRT, there was no significant difference in planning target volume dose distribution. The mean volume of ipsilateral bony orbit received more than 20 Gy, a suggested threshold for bone growth inhibition. The V20 Gy was 73% for the ET, 57% for the LFT, 87% for the CRT, 65% for the IMRT, 66% for the tomotherapy, and 2.7% for the SBRT. This work supports the potential use of IMRT and SBRT to spare normal tissues in these patients.

References

Feb 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J H SilberA T Meadows
Sep 1, 1988·International Journal of Radiation Oncology, Biology, Physics·B McCormickT LoSasso
May 1, 1982·CA: a Cancer Journal for Clinicians·D H Abramson
Feb 1, 1995·The British Journal of Ophthalmology·J L HungerfordJ E Kingston
Feb 1, 1995·The British Journal of Ophthalmology·N M TomaD Doughty
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·P J EifelP R Thomas
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
Jan 1, 1993·International Ophthalmology Clinics·J A ShieldsP De Potter
Nov 1, 1996·Archives of Ophthalmology·A L MurphreeC J Gomer
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C KasteC B Pratt
Jul 31, 1998·Archives of Ophthalmology·N E BechrakisM H Foerster
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L FriedmanA T Meadows
Jan 22, 2002·The British Journal of Ophthalmology·Dan S GombosJohn L Hungerford
Apr 25, 2002·Journal of Pediatric Hematology/oncology·Thomas E MerchantBarrett Haik
Jun 5, 2002·Ophthalmology·Livia LumbrosoLaurence Desjardins
Jun 12, 2004·Clinical Oncology : a Journal of the Royal College of Radiologists·M J KrasinT E Merchant
Jun 16, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Isabelle AertsErica Quintana
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ruth A KleinermanJoseph F Fraumeni
Jan 5, 2007·Journal of the National Cancer Institute·Ruth A KleinermanJoseph F Fraumeni
Feb 13, 2007·International Journal of Radiation Oncology, Biology, Physics·Márcio Lemberg ReisnerEdson Marchiori
Jan 18, 2008·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Karin DieckmannRichard Pötter
Feb 23, 2008·Clinical & Experimental Ophthalmology·Francis L MunierRaphaël Moeckli
Dec 27, 2011·International Journal of Radiation Oncology, Biology, Physics·Eman EldebawyCarolyn R Freeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.